Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Edwards

Showing results (1021-1030 of 1,259) with videos related to

Pageof 126
Sort By:
Oncogene|December 7, 2018
Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profilesShannon Grabosch, Mirna Bulatovic, Feitianzhi Zeng, et al.
Cancer|April 15, 1997
A case-matched molecular comparison of extraovarian versus primary ovarian adenocarcinomaL D Kowalski, A I Kanbour, F V Price, et al.
Nature|December 12, 1991
Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognitionR E Phillips, S Rowland-Jones, D F Nixon, et al.
Bioorganic & Medicinal Chemistry Letters|September 23, 2006
Identification of 2-arylbenzimidazoles as potent human histamine H4 receptor ligandsAlice Lee-Dutra, Kristen L Arienti, Daniel J Buzard, et al.
Journal of Medicinal Chemistry|March 3, 2015
Design, synthesis, and evaluation of NO-donor containing carbonic anhydrase inhibitors to lower intraocular pressureQinhua Huang, Eugene Y Rui, Morena Cobbs, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2024
Controlling CAR-T cell activity and specificity with synthetic SparX adaptersJustin P Edwards, Jeffrey S Swers, Janine M Buonato, et al.
Blood|February 5, 2005
In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutationsLisa M Schimanski, Hal Drakesmith, Alison T Merryweather-Clarke, et al.
Research Square|October 27, 2023
NK Receptors Replace CD28 As the Dominant Source of Signal 2 for Cognate Recognition of Cancer Cells by TAA-specific Effector CD8<sup>+</sup> T CellsBowen Dong, Nataša Obermajer, Takemasa Tsuji, et al.
Cell Reports|October 6, 2017
Prostaglandin E2 Leads to the Acquisition of DNMT3A-Dependent Tolerogenic Functions in Human Myeloid-Derived Suppressor CellsJavier Rodríguez-Ubreva, Francesc Català-Moll, Nataša Obermajer, et al.
Scientific Reports|September 24, 2016
Elemental characterisation of melanin in feathers via synchrotron X-ray imaging and absorption spectroscopyNicholas P Edwards, Arjen van Veelen, Jennifer Anné, et al.
Pageof 126

Showing results (1021-1030 of 1,259) with videos related to

Sort By:
Pageof 126
Oncogene|December 7, 2018
Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profilesShannon Grabosch, Mirna Bulatovic, Feitianzhi Zeng, et al.
Cancer|April 15, 1997
A case-matched molecular comparison of extraovarian versus primary ovarian adenocarcinomaL D Kowalski, A I Kanbour, F V Price, et al.
Nature|December 12, 1991
Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognitionR E Phillips, S Rowland-Jones, D F Nixon, et al.
Bioorganic & Medicinal Chemistry Letters|September 23, 2006
Identification of 2-arylbenzimidazoles as potent human histamine H4 receptor ligandsAlice Lee-Dutra, Kristen L Arienti, Daniel J Buzard, et al.
Journal of Medicinal Chemistry|March 3, 2015
Design, synthesis, and evaluation of NO-donor containing carbonic anhydrase inhibitors to lower intraocular pressureQinhua Huang, Eugene Y Rui, Morena Cobbs, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2024
Controlling CAR-T cell activity and specificity with synthetic SparX adaptersJustin P Edwards, Jeffrey S Swers, Janine M Buonato, et al.
Blood|February 5, 2005
In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutationsLisa M Schimanski, Hal Drakesmith, Alison T Merryweather-Clarke, et al.
Research Square|October 27, 2023
NK Receptors Replace CD28 As the Dominant Source of Signal 2 for Cognate Recognition of Cancer Cells by TAA-specific Effector CD8<sup>+</sup> T CellsBowen Dong, Nataša Obermajer, Takemasa Tsuji, et al.
Cell Reports|October 6, 2017
Prostaglandin E2 Leads to the Acquisition of DNMT3A-Dependent Tolerogenic Functions in Human Myeloid-Derived Suppressor CellsJavier Rodríguez-Ubreva, Francesc Català-Moll, Nataša Obermajer, et al.
Scientific Reports|September 24, 2016
Elemental characterisation of melanin in feathers via synchrotron X-ray imaging and absorption spectroscopyNicholas P Edwards, Arjen van Veelen, Jennifer Anné, et al.
Pageof 126